Access cutting-edge graft-versus-host disease treatment through this clinical trial at a research site in Commack. Study-provided care at no cost to qualified participants.
Access graft-versus-host disease specialists in Commack at no cost
This study follows strict safety protocols and ethical guidelines
All study-related graft-versus-host disease treatment provided free
The purpose of this study is to find out whether photobiomodulation/PBM therapy using the Thor LX2.3 therapy system is a safe and effective treatment for oral Graft-Versus-Host Disease/GVHD.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this graft-versus-host disease clinical trial in Commack, NY
If you're searching for graft-versus-host disease treatment options in Commack, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Commack research site is actively enrolling participants for this clinical trial. You'll receive care from experienced graft-versus-host disease specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.